carbapenems has been researched along with flomoxef in 6 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (flomoxef) | Trials (flomoxef) | Recent Studies (post-2010) (flomoxef) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 210 | 25 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Ito, K; Ogata, H | 1 |
| Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL | 1 |
| Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Abdul Jabar, K; Abu Bakar, S; Ahmed Khan, A; Chong, CW; Harun, A; Ismail, Z; Jasni, AS; Karunakaran, R; Kong, ZX; Lau, MY; Lee, YQ; Leong, KC; Lim, VKE; Mak, ST; Masri, SN; Md Noor, SS; Mohd Taib, N; Ngoi, ST; Ponnampalavanar, S; Ramli, R; Salleh, SA; Tan, SC; Tee, LH; Teh, CSJ; Tengku Jamaluddin, TZM; Woon, JJ; Yap, PSX | 1 |
6 other study(ies) available for carbapenems and flomoxef
| Article | Year |
|---|---|
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
A multicentre study to determine the
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Malaysia | 2023 |